A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer (EndoMAP)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04486352 |
Recruitment Status :
Recruiting
First Posted : July 24, 2020
Last Update Posted : December 26, 2023
|
Sponsor:
Alliance Foundation Trials, LLC.
Collaborators:
Genentech, Inc.
Foundation Medicine
Pfizer
Eli Lilly and Company
Information provided by (Responsible Party):
Alliance Foundation Trials, LLC.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Recruiting |
---|---|
Estimated Primary Completion Date : | October 1, 2025 |
Estimated Study Completion Date : | October 2026 |
Publications: